Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-30

Clinical Trial Update: Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for deferoxamine in intracerebral hemorrhage has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferoxamine (deferoxamine)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: COMPLETED | Results posted: 2019-05-30